News
High-Value Microsoft still has Plenty of Room to Run
Microsoft may be highly valued (NASDAQ: MSFT), but the company and stock price still have plenty of room to run. Valuation, the P/E multiple, and market cap are fickle things and driven by desire
Arete Ethik Invest legt ethischen Rentenfonds auf
[Zürich, 25. Oktober 2023] - Die seit mehr als 28 Jahren auf ethisch nachhaltige Geldanlagen spez
Over Sold and Left for Dead, High Yield Verizon Raises Guidance
Verizon (NYSE: VZ) stock presents a compelling value-to-yield combination that should have the market for this stock boiling. The stock trades at a ridiculously low 7X its earnings while paying
Is Conagra Brands a Savvy Buy or a Value Trap?
The classic definition of a value trap is a stock or investment that appears to be trading at a cheap price and has valuation metrics such as its price-to-earnings (P/E) ratio that signals it has
3 Tech Titans Report This Week: Here’s How to Play Them
Earnings season is ramping up, with many companies already coming in ahead of expectations in what will be an eagerly watched couple of weeks. Investors will have a lot to chew on as companies
Chevron Bolsters Portfolio, Snapping Up Hess in $53 Billion Deal
Shares of Chevron Corp. (NYSE: CVX) gapped down hard on October 23 after saying it would buy fellow S&P 500 component Hess Corp. (NYSE: HES) in an all-stock deal valued at $53 billion.
Under
The Value Deepens for Medtech Stocks: Reversal Imminent
Results from Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad
Time to Buy Warner Bros. Discovery On Its March to Profitability?
Media and entertainment giant Warner Bros. Discovery Inc. (NYSE: WBD) has hit a major milestone among streaming service providers: profitability. Streaming and profits are two words rarely
Is It Time To Strike on CrowdStrike as a Secure Momentum Play?
When it comes to the momentum investment strategy, CrowdStrike Holdings, Inc. (NASDAQ:CRWD) checks many of the boxes.
From a technical perspective, the cybersecurity play boasts a 70 relative
Bargain Alert: Crocs a Footwear Brand With Single Digit P/E Ratio
Crocs, Inc. (NASDAQ: CROX) is the Colorado headquartered foam clog maker. We all know them to see and probably have a pair lying around the house, and if you’re a long-term investor in their
Institutions Buy Consumer Staples, is the Bottom in?
Consumer staples are beaten down. These stocks are down double-digits from their recent highs and trading significant support levels, suggesting the bottom is in. While near-term headwinds impact
Fastenal or Simpson Manufacturing: Which is the Better Buy?
Fastenal (NASDAQ: FAST) and Simpson Manufacturing (NYSE: SSD) are in similar businesses with a similar outlook for growth, but 1 is the better buy for investors today. While Fastenal is growing
Faith In The Construction Boom? Follow Buffet's New Buys Here
Everyone is aware of Warren Buffett's new position in construction and homebuilder stocks. Since you are here browsing on MarketBeat, it is safe to assume that you are not everyone and are looking
Is Netflix a Buy After Its Post-Earnings Surge
Netflix, Inc. (NASDAQ: NFLX) stock shot up more than 16% in midday trading the day after it reported blockbuster earnings. But after rocketing past its 200-day and 50-day simple moving averages
Picture This: AI Ignites Double-Digit Revenue Growth at Adobe
Shares of Adobe Inc. (NASDAQ: ADBE) are forming a flat base with a 13% correction beneath a September 8 high of $570.24.
While many stocks have tumbled as AI optimism is taking a breather, Adobe
"Revolutionäre Exosomen: Eine neue Hoffnung für die Behandlung von Rückenmarksverletzungen"
NurExone ist ein Startup-Unternehmen, das von Experten der Universität Tel Aviv und des Technion in Israel gegründet wurde. Ihr Fokus liegt auf der Heilung und Wiederherstellung von Nerven
United Airlines Shares Fall Despite Solid Quarter
United Airlines (NASDAQ: UAL) shares fell following a better-than-expected Q3 report suggesting an entry point is developing. The news is offset by weaker-than-expected guidance caused by factors
Housing Starts Up, Homebuilders Down as Mortgage Rates Soar
Homebuilders as a group were trading lower following the U.S. Census Bureau’s report that more single-family homes were built in September than in August.
However, the actual number of homes
Water Ways: "Nachhaltige Revolution in der Landwirtschaft - abbaubare Kunststofffolien sparen Wasser und Geld"
Water Ways Technologies und seine Tochtergesellschaften bieten Bewässerungslösungen für die Landwirtschaft an. Das Besondere an dieser Technologie: Es handelt sich um eine
Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot
In the investing world, not all exchange-traded funds (ETFs) are created equal. Quite literally, most aren’t.
Most ETFs use a market capitalization weighting scheme to determine how much gets
Tesla Hits the Skids: 5 Critical Details from the Q3 Reports
Tesla (NASDAQ: TSLA) shares are skidding lower after the Q3 earnings report and may fall further. Near-term headwinds, including an intensifying price war, cut into results and the outlook for
3 Nasdaq-100 Stocks Trading Less Than 10x 2024 Earnings
If the Nasdaq-100 is driving toward 20,000, there will be at least a minor detour along the way.
Since riding a five-month winning streak as high as 15,932 this summer, the tech-heavy index has
Grid Dynamics Introduces Generative AI Product Data Starter Kit, Enabling Enterprises to Automate Product Catalog Attribution and Create Compelling Product Names and Descriptions at Scale
Key Takeaways:
- The Grid Dynamics Generative AI Product Data Starter Kit solves two pervasive challenges for enterprise companies-creating and maintaining high-fidelity product
3 Mega Caps With RSIs That Scream Oversold
No one wants to catch a falling knife, but everyone loves a bargain, and tracking stocks that have been falling hard can be a great way to spot one. One of the most common indicators out there
Oversold and Overextended, Abbott Laboratories is a Great Buy
Abbott Laboratories (NYSE: ABT) share price has trended lower for nearly 2 years, but that trend is over. The impact of COVID on sales and the post-COVID letdown were cause enough for the market